BPC‑157 & TB‑500 vs Ozempic: The Truth About “Healing Peptides”

Video will be live on Monday, May 4 at 1:00 PM Central Time. 

▪️ Join my channel to get access to perks or simply subscribe and turn on your notifications!
▪️ Download my FREE GLP-1/GIP Medication Information Sheet and 7-Day Best Weight Journal here.
▪️ Join my Empowerment Hub and discover sustainable, evidence-based solutions to transform your health and embrace self-care without guilt.

👉 Start your 14-day FREE trial today! 
Unlock expert coaching, exclusive resources, and a proven system that includes live Q&As and monthly toolkits, to help you create real, lasting change.
🔗 https://drdanshub.com

The Peptide Lie Your Social Feed Is Selling You

BPC-157 and TB-500 are all over wellness podcasts right now — marketed as the “natural,” unregulated alternative to GLP-1 medications. But before you inject anything from a vial labelled “Not for Human Consumption,” you need to hear this clinical audit.

In this video, I break down the real science behind so-called “healing peptides,” why regulators are flagging serious safety concerns — including cancer risk pathways — and the one psychological mechanism that explains why so many people swear these peptides “work.” 

Spoiler: it’s not the peptide doing the heavy lifting.

If you’re on Ozempic, Zepbound, or Mounjaro — or just trying to cut through the noise in the weight-loss space — this one is for you. No shame. No fearmongering. Just the evidence you deserve before you make that call.

Thanks for watching and always remember: small tweaks lead to massive peaks!

Don’t forget to hit the subscribe button for more insightful content, and consider joining our YouTube Members Membership for exclusive content and early access to weekly videos. 

📺 Watch These Next:
▪️ Watch This Before Taking Mounjaro
▪️ From Ozempic to Mounjaro
▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro
▪️ Managing Nausea from Ozempic, Wegovy and Trulicity!
▪️ Ozempic: Stomach Paralysis Update
▪️ How to Switch from Ozempic (or Wegovy) to Mounjaro
▪️ Ozempic Paralyzed My Stomach
▪️ How to Inject Mounjaro: step-by-step tutorial

🎯 Free Resources:
▪️ GLP-1/GIP Medication Info Sheet + 7-Day Food Journal
▪️ Total Daily Energy Expenditure (TDEE) Calculator – Find your optimal calorie intake


🛒 Recommended Products for Your Weight-Loss Journey:
▪️ Managing Constipation
▪️ Managing Heartburn
▪️ Protein Bars & Supplements
▪️ Activity Trackers & Scales

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

 

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link –
https://healthevolved.co/peptides

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

A Quick Summer Update (I’ll Be Back August 31!)

I’m taking a short break over the summer to rest, recharge, and make sure I can continue bringing you my best. I’ll be back with brand-new content on Monday, August 31—until then, you can stay connected through Dr. Dan’s Empowerment Hub or book a one-on-one consultation if you need support.

The Ozempic Pill Has a Ceiling — New Trial Proves It

New clinical trial data on orforglipron reveals a biological ceiling that every person on GLP-1 medications needs to understand. I’m breaking down the ATTAIN-MAINTAIN trial findings, explaining what the 15% threshold means for long-term weight management, and identifying exactly who is — and isn’t — a strong candidate for the transition to the Ozempic pill.

Reducing Your Zebound Dose Could Undo ALL Your Progress

The SURMOUNT MAINTAIN trial has delivered the most compelling evidence yet that obesity requires long-term management — not a finish line. New data reveals exactly what happens to your results at every dose decision, and the numbers make the choice undeniable.

The Retatrutide Paradox: Why This “Triple Threat” Works

Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.